Yukai Chen
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Risk factors and mechanisms of immune checkpoint inhibitor-related pneumonitis.
Journal: Human vaccines & immunotherapeutics
Published: October 13, 2025
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers.
Journal: Human vaccines & immunotherapeutics
Published: June 12, 2025
PRMT5 inhibits the ferroptosis of hepatocellular carcinoma via regulating RBM15/FTH1 signaling.
Journal: American journal of cancer research
Published: May 04, 2025
CYP8B1 inhibits hepatocellular carcinoma progression by repressing PAK4 transcription through inhibition of nuclear translocation of u-STAT1.
Journal: Cell death & disease
Published: March 15, 2025
m6A-modified circCCAR1 promotes malignant proliferation by enhancing KIF5B expression in hepatocellular carcinoma.
Journal: Journal of physiology and biochemistry
Published: February 24, 2025
NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα.
Journal: International immunopharmacology
Published: February 15, 2025
Inhibition of STING-induced mitochondrial Drp1/N-GSDMD-mediated MtDNA release alleviates Sepsis-induced lung injury.
Journal: Cellular and molecular life sciences : CMLS
Published: February 14, 2025
A Novel Ferroptosis-Related Gene Prognosis Signature and Identifying Atorvastatin as a Potential Therapeutic Agent for Hepatocellular Carcinoma.
Journal: Current issues in molecular biology
Published: February 07, 2025
IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γ.
Journal: International immunopharmacology
Published: July 27, 2024
The critical roles of STING in mitochondrial homeostasis.
Journal: Biochemical pharmacology
Published: August 29, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026